Validation of Gene Therapy for Mutant Mitochondria by Delivering Mitochondrial RNA Using a MITO-Porter
Here, we report on validating a mitochondrial gene therapy by delivering nucleic acids to mitochondria of diseased cells by a MITO-Porter, a liposome-based carrier for mitochondrial delivery. We used cells derived from a patient with a mitochondrial disease with a G625A heteroplasmic mutation in the...
Saved in:
Main Authors: | Eriko Kawamura (Author), Minako Maruyama (Author), Jiro Abe (Author), Akira Sudo (Author), Atsuhito Takeda (Author), Shingo Takada (Author), Takashi Yokota (Author), Shintaro Kinugawa (Author), Hideyoshi Harashima (Author), Yuma Yamada (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ergogenic effects of caffeine are mediated by myokines
by: Shingo Takada, et al.
Published: (2022) -
Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure
by: Masaya Tsuda, et al.
Published: (2018) -
Development of Liposomes That Target Axon Terminals Encapsulating Berberine in Cultured Primary Neurons
by: Ikuma Hori, et al.
Published: (2023) -
Validation of a therapeutic strategy involving the mitochondrial delivery of thiamine pyrophosphate using brain damage induced mouse model
by: Yuma Yamada, et al.
Published: (2022) -
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
by: Takaaki Furihata, et al.
Published: (2021)